Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

1.

Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota.

Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R.

Int J Antimicrob Agents. 2007 Jan;29(1):66-72. Epub 2006 Dec 1.

PMID:
17141481
2.

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, Rautelin H, Korpela R.

Aliment Pharmacol Ther. 2005 May 15;21(10):1263-72.

3.

Effects of multispecies probiotic combination on helicobacter pylori infection in vitro.

Myllyluoma E, Ahonen AM, Korpela R, Vapaatalo H, Kankuri E.

Clin Vaccine Immunol. 2008 Sep;15(9):1472-82. doi: 10.1128/CVI.00080-08. Epub 2008 Jun 25.

4.

Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.

Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):463-73.

5.
6.

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.

Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A.

Am J Gastroenterol. 2002 Nov;97(11):2744-9.

PMID:
12425542
7.
8.

Triple therapies plus different probiotics for Helicobacter pylori eradication.

Scaccianoce G, Zullo A, Hassan C, Gentili F, Cristofari F, Cardinale V, Gigliotti F, Piglionica D, Morini S.

Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):251-6.

PMID:
18727457
9.

Clinical studies on alleviating the symptoms of irritable bowel syndrome.

Kajander K, Korpela R.

Asia Pac J Clin Nutr. 2006;15(4):576-80.

10.

Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection.

Myllyluoma E, Kajander K, Mikkola H, Kyrönpalo S, Rasmussen M, Kankuri E, Sipponen P, Vapaatalo H, Korpela R.

Dig Liver Dis. 2007 Jun;39(6):516-23. Epub 2007 Apr 11.

PMID:
17433799
11.

Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.

Kim N, Park SH, Seo GS, Lee SW, Kim JW, Lee KJ, Shin WC, Kim TN, Park MI, Park JJ, Hong SJ, Shim KN, Kim SW, Shin YW, Chang YW, Chun HJ, Lee OJ, Jeon WJ, Park CG, Cho CM, Park CH, Won SY, Lee GH, Park KS, Shin JE, Kim HU, Park JY, Chae HS, Song GA, Kim JG, Yoon BC, Seol S, Jung HC, Chung IS.

Helicobacter. 2008 Dec;13(6):542-9. doi: 10.1111/j.1523-5378.2008.00648.x.

PMID:
19166420
12.

Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy.

Plummer SF, Garaiova I, Sarvotham T, Cottrell SL, Le Scouiller S, Weaver MA, Tang J, Dee P, Hunter J.

Int J Antimicrob Agents. 2005 Jul;26(1):69-74.

PMID:
15967639
13.

Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?

Collado MC, Meriluoto J, Salminen S.

J Dairy Sci. 2007 Jun;90(6):2710-6.

PMID:
17517710
14.

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.

Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):48-57. Epub 2007 Oct 5.

15.
16.

Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques.

Tanaka J, Fukuda Y, Shintani S, Hori K, Tomita T, Ohkusa T, Matsumoto T, Miwa H.

J Med Microbiol. 2005 Mar;54(Pt 3):309-14.

PMID:
15713617
17.

Effect of probiotics on preventing disruption of the intestinal microflora following antibiotic therapy: a double-blind, placebo-controlled pilot study.

Madden JA, Plummer SF, Tang J, Garaiova I, Plummer NT, Herbison M, Hunter JO, Shimada T, Cheng L, Shirakawa T.

Int Immunopharmacol. 2005 Jun;5(6):1091-7.

PMID:
15829425
18.

The role of probiotics in the treatment and prevention of Helicobacter pylori infection.

Hamilton-Miller JM.

Int J Antimicrob Agents. 2003 Oct;22(4):360-6. Review.

PMID:
14522098
19.

Macrolide resistance in the normal microbiota after Helicobacter pylori treatment.

Jakobsson H, Wreiber K, Fall K, Fjelstad B, Nyrén O, Engstrand L.

Scand J Infect Dis. 2007;39(9):757-63.

PMID:
17701712
20.

Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children.

Goldman CG, Barrado DA, Balcarce N, Rua EC, Oshiro M, Calcagno ML, Janjetic M, Fuda J, Weill R, Salgueiro MJ, Valencia ME, Zubillaga MB, Boccio JR.

Nutrition. 2006 Oct;22(10):984-8. Epub 2006 Sep 15.

PMID:
16978844

Supplemental Content

Support Center